Panion & BF Biotech Inc (1760) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.039x

Based on the latest financial reports, Panion & BF Biotech Inc (1760) has a cash flow conversion efficiency ratio of 0.039x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$73.31 Million ≈ $2.31 Million USD) by net assets (NT$1.90 Billion ≈ $59.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Panion & BF Biotech Inc balance sheet quality to measure how much of total assets are equity-financed.

Panion & BF Biotech Inc - Cash Flow Conversion Efficiency Trend (2009–2024)

This chart illustrates how Panion & BF Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 1760 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Panion & BF Biotech Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Panion & BF Biotech Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
MAX Automation SE XETRA:MXHN	0.111x
Amaero Ltd AU:3DA	-0.190x
Immunic Inc NASDAQ:IMUX	2.889x
Acme United Corporation NYSE MKT:ACU	-0.019x
Amplify Energy Corp NYSE:AMPY	-0.030x
Silver Mountain Resources Inc V:AGMR	-0.044x
Liberty Global PLC Class B NASDAQ:LBTYB	0.023x
Kian Shen Corp TW:1525	-0.021x

Annual Cash Flow Conversion Efficiency for Panion & BF Biotech Inc (2009–2024)

The table below shows the annual cash flow conversion efficiency of Panion & BF Biotech Inc from 2009 to 2024. For the full company profile with market capitalisation and key ratios, see 1760 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	NT$1.92 Billion ≈ $60.56 Million	NT$351.19 Million ≈ $11.06 Million	0.183x	+96.80%
2023-12-31	NT$1.91 Billion ≈ $60.21 Million	NT$177.42 Million ≈ $5.59 Million	0.093x	-61.96%
2022-12-31	NT$2.01 Billion ≈ $63.24 Million	NT$489.87 Million ≈ $15.43 Million	0.244x	+17.59%
2021-12-31	NT$1.93 Billion ≈ $60.90 Million	NT$401.23 Million ≈ $12.64 Million	0.208x	+1868.28%
2020-12-31	NT$1.24 Billion ≈ $39.07 Million	NT$-14.55 Million ≈ $-458.56K	-0.012x	-117.54%
2019-12-31	NT$1.36 Billion ≈ $42.83 Million	NT$90.98 Million ≈ $2.87 Million	0.067x	+15.01%
2018-12-31	NT$1.35 Billion ≈ $42.55 Million	NT$78.58 Million ≈ $2.48 Million	0.058x	-57.36%
2017-12-31	NT$835.25 Million ≈ $26.31 Million	NT$113.97 Million ≈ $3.59 Million	0.136x	-37.91%
2016-12-31	NT$806.41 Million ≈ $25.41 Million	NT$177.22 Million ≈ $5.58 Million	0.220x	+192.12%
2015-12-31	NT$775.03 Million ≈ $24.42 Million	NT$58.30 Million ≈ $1.84 Million	0.075x	-29.74%
2014-12-31	NT$710.84 Million ≈ $22.40 Million	NT$76.11 Million ≈ $2.40 Million	0.107x	-18.47%
2013-12-31	NT$656.55 Million ≈ $20.68 Million	NT$86.22 Million ≈ $2.72 Million	0.131x	+825.27%
2012-12-31	NT$278.86 Million ≈ $8.79 Million	NT$3.96 Million ≈ $124.70K	0.014x	+111.67%
2011-12-31	NT$296.98 Million ≈ $9.36 Million	NT$-36.12 Million ≈ $-1.14 Million	-0.122x	-164.01%
2010-12-31	NT$301.62 Million ≈ $9.50 Million	NT$-13.89 Million ≈ $-437.77K	-0.046x	-119.43%
2009-12-31	NT$324.61 Million ≈ $10.23 Million	NT$76.98 Million ≈ $2.43 Million	0.237x	--

About Panion & BF Biotech Inc

TW:1760 Taiwan Biotechnology

Market Cap

$158.29 Million

NT$5.02 Billion TWD

Market Cap Rank

#17379 Global

#866 in Taiwan

Share Price

NT$58.60

Change (1 day)

+1.03%

52-Week Range

NT$58.00 - NT$73.20

All Time High

NT$228.22